Related Experiment Video
Updated: May 17, 2026

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo
Published on: December 19, 2025
[Current registry studies of acute ischemic stroke]
R Veltkamp1, E Jüttler, T Pfefferkorn
1Neurologische Klinik, Universitätsklinik Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Deutschland. roland.veltkamp@med.uni-heidelberg.de
Study registries are crucial for evaluating new stroke therapies and treatments in clinical practice. They provide real-world data to confirm findings from randomized trials and guide future research for better patient outcomes.
Area of Science:
- Neurology
- Clinical Trials
- Health Informatics
Context:
- Study registries are essential for assessing the real-world safety and efficacy of novel stroke interventions.
- Existing registries like SITS-MOST have validated findings from intravenous thrombolysis trials.
- Newer registries are investigating interventional thrombectomy, basilar artery occlusion, and treatments for malignant middle cerebral artery infarction.
Purpose:
- To highlight the role of various stroke study registries in evaluating therapeutic interventions.
- To emphasize the need for randomized controlled trials to confirm clinical benefits suggested by registry data.
- To introduce the RASUNOA registry, focusing on stroke during novel oral anticoagulant therapy.
Summary:
- Registries such as SITS-MOST, BASICS, DESTINY-R, and RASUNOA are instrumental in stroke research.
- They provide data on intravenous thrombolysis, interventional thrombectomy, basilar artery occlusion, hemicraniectomy, and stroke related to new oral anticoagulants.
- Registry findings often inform the design and necessity of randomized controlled trials for definitive evidence.
Impact:
- Registry data complements randomized trials, offering insights into routine clinical practice.
- These initiatives accelerate the evaluation of new stroke treatments, potentially improving patient care.
- The ongoing documentation in registries facilitates a deeper understanding of stroke management and outcomes.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Hemorrhagic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
